Search by Drug Name or NDC

    NDC 59651-0204-10 Capecitabine 150 mg/1 Details

    Capecitabine 150 mg/1

    Capecitabine is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Aurobindo Pharma Limited. The primary component is CAPECITABINE.

    Product Information

    NDC 59651-0204
    Product ID 59651-204_aabd86be-2d1e-46dc-a31f-9a3cb28e94f4
    Associated GPIs 21300005000320
    GCN Sequence Number 039780
    GCN Sequence Number Description capecitabine TABLET 150 MG ORAL
    HIC3 V1B
    HIC3 Description ANTINEOPLASTIC - ANTIMETABOLITES
    GCN 31611
    HICL Sequence Number 018385
    HICL Sequence Number Description CAPECITABINE
    Brand/Generic Generic
    Proprietary Name Capecitabine
    Proprietary Name Suffix n/a
    Non-Proprietary Name Capecitabine
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 150
    Active Ingredient Units mg/1
    Substance Name CAPECITABINE
    Labeler Name Aurobindo Pharma Limited
    Pharmaceutical Class Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA210604
    Listing Certified Through 2024-12-31

    Package

    NDC 59651-0204-10 (59651020410)

    NDC Package Code 59651-204-10
    Billing NDC 59651020410
    Package 1 BLISTER PACK in 1 CARTON (59651-204-10) / 10 TABLET in 1 BLISTER PACK
    Marketing Start Date 2018-04-17
    NDC Exclude Flag N
    Pricing Information N/A